Medicine & Life Sciences

1. Amphiregulin 100%
2. Quality Improvement 97%
3. Pemphigus 79%
4. Graft vs Host Disease 69%
5. Dermatology 67%
6. Patient Safety 65%
7. Bullous Pemphigoid 55%
8. Dermatologists 52%
9. Cutaneous Lupus Erythematosus 49%
10. Lenalidomide 44%
11. Severe Acute Respiratory Syndrome 42%
12. Skin 42%
13. Grandparents 42%
14. Coronavirus 41%
15. Hyperpigmentation 40%
16. Rituximab 36%
17. Epidermolysis Bullosa 33%
18. Multiple Myeloma 32%
19. Patient-Centered Care 27%
20. Benign Familial Pemphigus 27%
21. Vaccination 26%
22. Quality of Life 25%
23. Hydroxychloroquine 22%
24. Child 21%
25. Mothers 21%
26. Cicatrix 20%
27. Resource Allocation 19%
28. Mutation 18%
29. Pruritus 17%
30. Prednisone 16%
31. Rare Diseases 16%
32. Skin Diseases 16%
33. Lamin Type A 15%
34. Lipodystrophy 14%
35. Therapeutics 14%
36. Genes 13%
37. Delivery of Health Care 12%
38. Aptitude 11%
39. Psychology 11%
40. Epidermolysis Bullosa Acquisita 10%
41. Root Cause Analysis 10%
42. Hemidesmosomes 9%
43. Dermatitis Herpetiformis 9%
44. Viral Vaccines 9%
45. Pain 9%
46. Ulcerative Colitis 8%
47. Epidermal Growth Factor 8%
48. ErbB Receptors 8%
49. Desmosomes 8%
50. National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division 8%